France is set to implement organized cervical cancer screening nationwide starting in 2018, as announced in the January 23, 2017, issue of the Weekly Epidemiological Bulletin (BEH). This vital step addresses a disease affecting around 3,000 women annually in France, resulting in over 1,000 deaths each year. As the 10th most common cancer among French women, cervical cancer's prognosis often worsens without early intervention—yet it is largely preventable through timely detection. While HPV vaccination remains debated, regular Pap smears effectively identify and treat precancerous lesions and early-stage cancers. Health experts strongly recommend women aged 25 to 65 undergo screening every three years, though 40% in this group currently do not follow through consistently.
Piloted for three years across 13 departments—modeled after successful breast cancer screening initiatives—the program sent postal invitations to over 1 million women who hadn't had a Pap smear in three years. A follow-up letter reached 455,500 participants. Results were promising: 62% completed smears, with 11% directly attributed to the invitation. Building on this success, the initiative expands countrywide in 2018.
Prevention remains our strongest defense—early action saves lives.
